PremieBreathe, a portable infant respiratory device, is being developed by students at Yale University to help treat premature infants in the developing world.
The US FDA has approved Bevespi Aerosphere inhalation aerosol indicated for the long-term, maintenance treatment of airflow obstruction in patients with COPD.
3M Drug Delivery Systems has developed the 3M Intelligent Control Inhaler, which is described as an intuitive device designed to deliver accurate doses of medication.
ResApp has raised $9.74 million for its new smartphone-based system designed to diagnose respiratory ailments.
The new website provides greater insight into Nihon Kohden’s products that help professionals across the healthcare system improve the quality of care while controlling costs.
The antimicrobial agent Mul-1867 for the treatment of bacterial lung infections in cystic fibrosis patients has been granted Orphan Drug Designation by the FDA.
The FDA has accepted Genentech’s Biologics License Application and granted Priority Review for the its product atezolizumab for the treatment of non-small cell lung cancer.
Raptor Pharmaceutical Corp has announced its first commercial sale of Quinsair, a levofloxacin inhalation solution for cystic fibrosis treatment, in Germany and Denmark.
RT consulted with some leading device manufacturers about today’s airway clearance products and the industry and technology trends in the next few years.
Several types of aerosol delivery technology exist on the market today, but depending on the specific disease being treated, certain devices may make more sense for patients.
The Oncologic Drugs Advisory Committee has voted in favor of the FDA waiting for results of an ongoing clinical trial before approving the EGFR inhibitor rociletinib for non-small cell lung cancer.
Bronchial thermoplasty is equally effective in improving the quality of life of severe refractory asthmatics regardless of the demographic factors associated with their healthcare disparities.
CSA Medical Inc has initiated treatments in a clinical study to evaluate the safety and feasibility of treating chronic bronchitis patients with the RejuvenAir System, a "cryotherapy" spray that freezes and ablates unwanted tissue inside the lungs.
Cleveland Clinic researchers have discovered a potential new remedy for the millions of asthma sufferers who are not responding to traditional bronchodilator treatments.
A smartphone-based system for diagnosing respiratory diseases achieved an accuracy of 89% in a clinical study of pediatric patients.
Cohero Health has announced the completion of their connected metered dose inhaler eMDI.
EarlySense has launched its new Multi-Parameter Alert capability, which combines the monitoring of a patient's heart rate and respiratory rate and can be used to detect sepsis.
Propeller Health and Boehringer Ingelheim are launching a first-of-its-kind commercial partnership to help people living with COPD and asthma better manage their disease.
The Indian Patent Office has refused a patent to Vertex Pharmaceuticals for its cystic fibrosis drug Orkambi.
A biologic therapy for influenza A has been granted Fast Track Designation from the US FDA.